Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.58 - $17.36 $471,728 - $603,034
34,737 New
34,737 $546,000
Q2 2023

Aug 11, 2023

SELL
$13.28 - $15.96 $132 - $159
-10 Reduced 0.09%
10,942 $154,000
Q1 2023

May 12, 2023

BUY
$14.26 - $22.1 $142 - $221
10 Added 0.09%
10,952 $169,000
Q4 2022

Feb 10, 2023

BUY
$14.85 - $19.04 $162,488 - $208,335
10,942 New
10,942 $179,000
Q2 2022

Aug 11, 2022

SELL
$9.11 - $13.98 $121,317 - $186,171
-13,317 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$6.87 - $11.11 $91,487 - $147,951
13,317 New
13,317 $123,000
Q4 2021

Feb 11, 2022

SELL
$7.7 - $37.13 $24.6 Million - $119 Million
-3,195,854 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$26.46 - $37.15 $3.69 Million - $5.19 Million
139,641 Added 4.57%
3,195,854 $109 Million
Q2 2021

Aug 13, 2021

SELL
$32.73 - $47.95 $25.7 Million - $37.6 Million
-784,521 Reduced 20.43%
3,056,213 $112 Million
Q1 2021

May 13, 2021

BUY
$40.39 - $56.73 $10.3 Million - $14.4 Million
253,895 Added 7.08%
3,840,734 $172 Million
Q4 2020

Feb 10, 2021

BUY
$51.77 - $66.18 $10.6 Million - $13.5 Million
204,288 Added 6.04%
3,586,839 $205 Million
Q3 2020

Nov 12, 2020

SELL
$43.8 - $58.16 $6.52 Million - $8.66 Million
-148,937 Reduced 4.22%
3,382,551 $174 Million
Q2 2020

Aug 13, 2020

BUY
$37.05 - $65.03 $10.9 Million - $19.1 Million
294,105 Added 9.08%
3,531,488 $175 Million
Q1 2020

May 13, 2020

BUY
$33.63 - $69.4 $29.1 Million - $60 Million
864,661 Added 36.44%
3,237,383 $133 Million
Q4 2019

Feb 12, 2020

BUY
$31.7 - $69.93 $49.5 Million - $109 Million
1,562,662 Added 192.91%
2,372,722 $148 Million
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $16.2 Million - $31.5 Million
810,060 New
810,060 $27.5 Million
Q1 2018

May 10, 2018

SELL
$20.04 - $29.71 $5.01 Million - $7.43 Million
-250,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$17.65 - $18.99 $4.41 Million - $4.75 Million
250,000
250,000 $4.75 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.